Genfit Stock Forecast, Price & News

Genfit (NASDAQ:GNFT) Frequently Asked Questions

Is Genfit a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genfit in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Genfit stock.
View analyst ratings for Genfit or view top-rated stocks.

How has Genfit's stock been impacted by COVID-19 (Coronavirus)?

Genfit's stock was trading at $14.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GNFT shares have decreased by 76.5% and is now trading at $3.35.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for GNFT?

3 brokers have issued twelve-month price targets for Genfit's stock. Their forecasts range from $7.00 to $15.00. On average, they anticipate Genfit's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 228.4% from the stock's current price.
View analysts' price targets for Genfit or view top-rated stocks among Wall Street analysts.

Who are Genfit's key executives?

Genfit's management team includes the following people:

• Pascal Prigent, CEO & EVP-Marketing & Development
• Dean W. Hum, Chief Operating Officer
• Thomas Baetz, Chief Financial Officer
• Carol L. Addy, Chief Medical Officer
• Stefanie Magner, Chief Compliance Officer

What is Jean-François Mouney's approval rating as Genfit's CEO?

3 employees have rated Genfit CEO Jean-François Mouney on Glassdoor.com. Jean-François Mouney has an approval rating of 29% among Genfit's employees. This puts Jean-François Mouney in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Genfit's key competitors?

Some companies that are related to Genfit include Graphite Bio (GRPH), Ikena Oncology (IKNA), Precision BioSciences (DTIL), Talaris Therapeutics (TALS), Athira Pharma (ATHA), Tarsus Pharmaceuticals (TARS), Taysha Gene Therapies (TSHA), Curis (CRIS), Aerie Pharmaceuticals (AERI), Autolus Therapeutics (AUTL), CEL-SCI (CVM), Poseida Therapeutics (PSTX), Jounce Therapeutics (JNCE), Ambrx Biopharma (AMAM) and Cellectis (CLLS).
View all of GNFT's competitors.

What other stocks do shareholders of Genfit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genfit investors own include Intercept Pharmaceuticals (ICPT), InterDigital (IDCC), STAG Industrial (STAG), Gilead Sciences (GILD), Occidental Petroleum (OXY), Vaxart (VXRT), Exxon Mobil (XOM), Zynerba Pharmaceuticals (ZYNE), Aimmune Therapeutics (AIMT) and Amarin (AMRN).

When did Genfit IPO?

(GNFT) raised $132 million in an IPO on Wednesday, March 27th 2019. The company issued 5,000,000 shares at a price of $26.33 per share. SVB Leerink and Barclays acted as the underwriters for the IPO and Bryan, Garnier, Natixis, Roth Capital Partners and H.C. Wainwright & Co. were co-managers.

What is Genfit's stock symbol?

Genfit trades on the NASDAQ under the ticker symbol "GNFT."

Who are Genfit's major shareholders?

Genfit's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (0.69%) and Citadel Advisors LLC (0.05%).

Which institutional investors are selling Genfit stock?

GNFT stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, and Citadel Advisors LLC.

How do I buy shares of Genfit?

Shares of GNFT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Genfit's stock price today?

One share of GNFT stock can currently be purchased for approximately $3.35.

How much money does Genfit make?

Genfit has a market capitalization of $153.53 million and generates $8.86 million in revenue each year.

How many employees does Genfit have?

Genfit employs 130 workers across the globe.

What is Genfit's official website?

The official website for Genfit is www.genfit.com.

Where are Genfit's headquarters?

Genfit is headquartered at PARC 885 AVENUE EUGENE AVINEE, LOOS I0, 59120.

How can I contact Genfit?

Genfit's mailing address is PARC 885 AVENUE EUGENE AVINEE, LOOS I0, 59120. The company can be reached via phone at (332) 016-4000 or via email at [email protected].